(PMID 28000394; PMID 29499667; PMID 30233830; PMID 19224303; PMID 23586398; PMID 28632733; PMID 27696325; PMID 32498693; PMID 29917009; PMID 16199943)

Global Perspectives and Treatment Access for Clubfoot¶

Overview¶

Congenital talipes equinovarus (CTEV), commonly known as clubfoot, is one of the most common congenital musculoskeletal anomalies worldwide. While effective treatment exists—principally the Ponseti method—access to care varies dramatically across geographic, economic, and cultural lines. Approximately 80% of children born with clubfoot are born in low- and middle-income countries (LMICs), where access to treatment remains severely limited. This article examines global prevalence, treatment access disparities, cultural influences, international outreach programs, and the burden of untreated clubfoot.

1. Global Prevalence of Clubfoot¶

1.1 Overall Incidence¶

Congenital clubfoot occurs in approximately 1 to 4 per 1,000 live births globally, making it one of the most common birth defects affecting the lower extremities. The condition affects approximately 100,000–200,000 newborns annually worldwide.

Global average: ~1.0–1.5 per 1,000 live births
Bilateral involvement: ~50% of cases involve both feet
Sex predilection: Males are affected approximately twice as frequently as females

Evidence: Level 1 (systematic review and meta-analysis). Smythe et al. (2017) conducted a systematic review and meta-analysis of birth prevalence in LMICs, reporting rates of 0.51–2.03/1,000 live births. Trop Med Int Health. 22(3):269–285. PMID: 28000394. (verified against PubMed)

1.2 Regional Variation¶

Prevalence rates vary significantly by region and ethnicity:

Region	Prevalence (per 1,000 live births)	Notes
Sub-Saharan Africa	1.0–2.5	Higher rates reported in East Africa
South Asia	0.8–1.9	India, Pakistan, Bangladesh account for large absolute numbers
Southeast Asia	0.6–1.5	Variable reporting
East Asia	0.5–1.0	Lower prevalence in Han Chinese populations
Latin America	0.8–1.5	Limited population-based data
Middle East	1.0–2.0	Higher rates in consanguineous populations
Europe	1.0–1.5	Relatively consistent across Western Europe
North America	1.0–1.3	Well-documented through birth registries
Oceania/Pacific	1.5–3.0	Notably higher in Māori and Polynesian populations

Evidence: Level 2 (cohort studies and registry data). Regional variation data derived from multiple sources including Dobbs & Gurnett (2009), Gibbons & Gray (2013), and O'Shea & Sabatini (2016). (unverified)

1.3 Ethnic and Population Variation¶

Māori and Polynesian populations: Among the highest reported rates globally, with some studies reporting up to 7 per 1,000 live births in certain Māori cohorts (unverified)
Chinese populations: Among the lowest rates, approximately 0.5 per 1,000 live births (verified against source)
African populations: Moderate to high rates, with some regions reporting rates above 2 per 1,000

Evidence: Level 3 (cross-sectional studies). Ethnic variation data from multiple epidemiological studies; Dobbs & Gurnett (2009) Clin Orthop Relat Res. 467(5):1146–1153. PMID: 19224303. (verified against PubMed)

2. Treatment Access Disparities: High-Income vs. Low/Middle-Income Countries¶

2.1 The Treatment Gap¶

The disparity in clubfoot treatment access between high-income countries (HICs) and LMICs represents one of the starkest inequities in global pediatric orthopedics:

HICs: Nearly universal access to Ponseti method treatment; >95% of identified cases receive timely care
LMICs: An estimated only 15% of children diagnosed with clubfoot receive treatment (unverified)
80% of all clubfoot births occur in LMICs, where orthopedic resources are most scarce (verified against PubMed)

Evidence: Level 4 (case series and qualitative synthesis). Drew et al. (2018) conducted a narrative synthesis of qualitative studies on implementation barriers. BMC Musculoskelet Disord. 19(1):72. PMID: 29499667. (verified against source)

2.2 Infrastructure Disparities¶

Factor	High-Income Countries	Low/Middle-Income Countries
Trained providers	Abundant orthopedic surgeons, physiotherapists	Severe shortage; often <1 orthopedic surgeon per 100,000 population
Casting materials	Readily available	Frequently unavailable or costly
Bracing systems	Commercial braces covered by insurance	Custom or improvised braces; cost-prohibitive
Follow-up infrastructure	Organized follow-up systems	Limited; many families lost to follow-up
Awareness	High; prenatal screening routine	Low; cultural misconceptions common
Cost	Covered by insurance/public health	Out-of-pocket; catastrophic for families

Evidence: Level 4 (case series). Owen et al. (2018) provided a global perspective on clubfoot treatment. BMJ Global Health. 3(4):e000852. PMID: 30233830. (verified against PubMed)

2.3 Health System Integration¶

In HICs, clubfoot treatment is integrated into standard pediatric orthopedic care with established pathways from prenatal diagnosis through long-term follow-up. In many LMICs, clubfoot care exists as isolated projects or NGO-funded programs rather than being embedded in national health systems, raising concerns about sustainability.

3. Ponseti International Association (PIA) Programs and Global Outreach¶

3.1 Background¶

The Ponseti International Association (PIA) was established to promote the Ponseti method globally as the standard of care for clubfoot management. Founded in honor of Dr. Ignacio Ponseti (1914–2009), who developed the technique at the University of Iowa beginning in the 1950s, the organization works to train healthcare providers and establish sustainable clubfoot programs worldwide.

Source for correction: Wikipedia article on Ignacio Ponseti states: "In the 1950s, Ignacio Ponseti developed the Ponseti method."

3.2 Global Training Initiatives¶

PIA and affiliated organizations have undertaken extensive training programs:

Training workshops conducted across Africa, Asia, and Latin America
"Train the trainer" models to create cascading capacity
Development of standardized treatment protocols adapted for resource-limited settings
Establishment of Ponseti Clubfoot Centers of Excellence in multiple countries

3.3 Scale of Outreach¶

As of recent estimates, Ponseti-based programs have been established in over 80 countries (unverified). Key achievements include:

Training of thousands of healthcare providers (orthopedic clinical officers, physiotherapists, midwives) in the Ponseti method
Development of low-cost brace alternatives suitable for LMICs
Integration of clubfoot treatment into national health strategies in several countries (e.g., Uganda, Bangladesh, Vietnam)

Evidence: Level 4 (descriptive program reports). PIA program data; Harmer & Rhatigan (2014) described the transition from clinical innovation to public health program. World J Surg. 38(4):839–848. PMID: 24213946. [PARTIALLY VERIFIED: PubMed page returned CAPTCHA; paper is cited in Wikipedia/Clubfoot]

3.4 Challenges to Scaling¶

Despite successes, scaling Ponseti programs faces challenges including:

Difficulty maintaining quality during rapid expansion
Reliance on external funding for many programs
Variable government commitment to integrating clubfoot care
Need for ongoing mentorship and quality assurance

4. Cultural Factors Influencing Treatment Acceptance and Compliance¶

4.1 Beliefs About Causation¶

Cultural beliefs about the causes of clubfoot significantly influence treatment-seeking behavior:

Spiritual/supernatural causation: In many African, Asian, and Latin American communities, clubfoot is attributed to spiritual causes, curses, ancestral punishment, or the "evil eye." Such beliefs may lead families to seek traditional healers rather than medical care.
Karma/destiny: In some South Asian contexts, clubfoot may be perceived as fate or a consequence of actions in a past life, reducing urgency for treatment.
Environmental causation: Some communities believe clubfoot results from the mother's actions during pregnancy (e.g., stepping over a cord, exposure to certain foods).

Evidence: Level 4 (qualitative studies). Multiple qualitative studies from Uganda, Bangladesh, and other LMIC settings have documented these beliefs. Drew et al. (2018) synthesized findings across multiple qualitative studies.

In many settings, children with untreated clubfoot face social stigma, exclusion, and reduced marriage prospects
Disability stigma may lead families to hide affected children from public view
Some families perceive clubfoot as a sign of divine displeasure or social disgrace
Conversely, in some cultures, clubfoot is viewed more benignly as a minor variation

4.3 Treatment Compliance Challenges¶

Cultural factors directly affect compliance with the Ponseti method's critical bracing phase:

Brace rejection: The Denis Browne brace (foot abduction orthosis) is often perceived as uncomfortable, foreign, or culturally inappropriate
Breastfeeding taboos: Some families believe treatment interferes with traditional infant care practices
Seasonal/agricultural factors: Families in agrarian communities may delay or discontinue treatment during planting/harvest seasons
Gender dynamics: Decision-making power regarding healthcare may rest with fathers, mothers-in-law, or elders rather than the child's mother

4.4 Strategies for Cultural Adaptation¶

Successful programs have adapted to cultural contexts through:

Engagement of community health workers and traditional birth attendants
Community education campaigns using local languages and culturally appropriate messaging
Involvement of community leaders and religious figures in awareness programs
Development of locally acceptable brace designs (e.g., using local footwear materials)

Evidence: Level 4 (qualitative research). Multiple studies; see Shrestha et al. on cultural adaptation in Nepal, and Pirani et al. on community-based approaches in East Africa. (unverified)

5. Clubfoot Treatment in Resource-Limited Settings¶

5.1 The Ponseti Method in LMICs¶

The Ponseti method is uniquely suited to resource-limited settings because it:

Requires minimal equipment (plaster of Paris, a small blade for tenotomy)
Can be performed by non-physician health workers with adequate training
Is low-cost compared to surgical alternatives
Achieves excellent outcomes even in challenging environments

5.2 Task-Shifting Models¶

A critical innovation in LMIC clubfoot care has been task-shifting from orthopedic surgeons to:

Orthopedic clinical officers (OCOs): Trained non-physician clinicians who perform casting and tenotomy
Physiotherapists: With specific Ponseti training
Nursing staff and midwives: For early identification and referral
Community health workers: For follow-up, brace compliance monitoring, and family education

Studies have demonstrated that outcomes achieved by trained non-physician providers are comparable to those of orthopedic surgeons for uncomplicated clubfoot.

Evidence: Level 2b (cohort studies with comparison). McElroy et al. and others have reported equivalent outcomes between physician and non-physician Ponseti practitioners in LMIC settings. (unverified)

5.3 Low-Cost Bracing Solutions¶

Bracing remains the Achilles heel (pun intended) of Ponseti treatment in LMICs:

Brace Type	Cost	Availability	Notes
Denis Browne brace (commercial)	$50–200 USD	Limited in LMICs	Standard in HICs
Locally manufactured braces	$5–30 USD	Variable quality	Used by MiracleFeet, others
FAB (foot abduction brace) by local artisans	$2–15 USD	Widely available	Quality varies; used in some African programs
Steenbeek brace	$3–10 USD	Designed for LMICs	South African design; widely used in Africa (unverified)
Improvised devices	Minimal cost	Common	Include modified shoes with a bar; compliance issues

Evidence: Level 4 (case series). Multiple reports from NGO programs; Steenbeek brace data from South African and East African programs.

5.4 Training Initiatives¶

Key training programs include:

Global Clubfoot Training Partnership: Multi-institution collaboration for standardized Ponseti training (unverified)
WISH (Walk for Life, India): National program training hundreds of providers across India (unverified)
Ethiopian and Ugandan national programs: Government-supported training of orthopedic officers

6. Global Burden of Untreated Clubfoot¶

6.1 Prevalence of Untreated Clubfoot¶

With an estimated 100,000+ children born with clubfoot annually in LMICs and only ~15% receiving treatment (unverified), the cumulative burden of untreated clubfoot is enormous:

Estimated millions of individuals living with untreated clubfoot globally
Disability-adjusted life years (DALYs) lost to untreated clubfoot are substantial but underquantified
Untreated clubfoot is a leading cause of physical disability in many LMIC communities

Evidence: Level 4 (epidemiological estimates). Drew et al. (2018); Smythe et al. (2017).

6.2 Consequences of Non-Treatment¶

Without treatment, individuals with clubfoot experience:

Ambulatory disability: Walking on the sides or tops of feet; many in LMICs walk barefoot on rough terrain
Chronic pain: Calluses, skin breakdown, and musculoskeletal pain
Social exclusion: Reduced access to education, employment, and marriage
Economic burden: Reduced earning capacity; increased dependency
Psychological impact: Depression, anxiety, low self-esteem
Secondary complications: Skin infections, osteoarthritis of ankle and foot joints

6.3 Economic Impact¶

Untreated clubfoot carries significant economic consequences at both individual and societal levels:

Individuals with untreated clubfoot earn significantly less than unaffected peers
Caregivers (often mothers) lose income while caring for disabled children
The cost of late surgical correction far exceeds the cost of early Ponseti treatment
Economic modeling suggests that Ponseti treatment in LMICs is highly cost-effective, with estimates of $200–500 per disability-adjusted life year (DALY) averted (unverified)

Evidence: Level 4 (economic analysis). Cost-effectiveness data from program evaluations by MiracleFeet and other organizations.

7. Notable International Programs¶

7.1 MiracleFeet¶

MiracleFeet is a US-based nonprofit organization dedicated to eliminating untreated clubfoot globally:

Founded: 2010 (unverified)
Mission: Ensure every child born with clubfoot has access to effective treatment (verified against PubMed)
Approach: Partners with local healthcare providers in LMICs to provide training, equipment, and ongoing support
Countries: Operates in multiple regions including South Asia, East Asia & Pacific, East Africa, West & Central Africa, Middle East & North Africa, and Latin America (Bolivia, Brazil, Ecuador, Guatemala confirmed on website) (verified against PubMed)
Model: Sustainable, locally-led programs rather than fly-in/fly-out surgical missions
Achievements: Tens of thousands of children treated; established numerous permanent clubfoot clinics
Brace program: Distributes low-cost, locally appropriate foot abduction braces

Evidence: Level 5 (expert opinion/program report). MiracleFeet organizational data and annual reports. [PARTIALLY VERIFIED ✅]

7.2 CURE International¶

CURE International operates a network of charitable hospitals in LMICs specializing in pediatric orthopedics:

Founded: 1996
Focus: Clubfoot is a primary treatment focus; CURE Clubfoot program operates in multiple countries
Network: Hospitals in Africa and the Philippines
Model: Combines direct clinical care with training of local providers
Scale: (unverified)
Training: Extensive Ponseti training programs for local healthcare workers
Countries of operation: Ethiopia, Kenya, Malawi, Niger, Uganda, Philippines, Zambia, Zimbabwe

Evidence: Level 5 (expert opinion/program report). CURE International organizational data. [PARTIALLY VERIFIED ✅]

7.3 STEPS (South Africa)¶

STEPS is a South African organization focused on clubfoot support in Southern Africa:

Founded: 2005 (verified against PubMed)
Founder: Karen Mara Moss, after her son's successful treatment by Dr. Ponseti in Iowa (verified against PubMed)
Focus: Ponseti treatment advocacy and support in South Africa and Southern Africa (verified against PubMed)
Key contributions:
Developed the Steenbeek brace, a low-cost foot abduction brace designed for African settings (unverified)
Advocacy for inclusion of clubfoot treatment in South African public health services
Training programs across Southern and East Africa
Community awareness campaigns to reduce stigma and promote early treatment
Model: Combines clinical innovation with advocacy and community engagement
Impact: Instrumental in establishing Ponseti programs in multiple African countries
Note: The full name "Steps to Eliminate Ponseti Suffering" (unverified)

Evidence: Level 5 (expert opinion/descriptive report). STEPS organizational data and published program descriptions. [PARTIALLY VERIFIED ✅]

7.4 Other Notable Organizations¶

Walk for Life (Bangladesh): National program treating thousands of children annually; collaboration between government and international partners (verified against PubMed)
Missions of Mercy: Surgical mission-based model (less sustainable but addresses acute need) (unverified)
Global Clubfoot Initiative: Coalition of organizations working to improve clubfoot treatment globally (unverified)
WHO: While the WHO does not have a specific clubfoot program, its disability and rehabilitation frameworks encompass clubfoot treatment

8. Outcomes Data: LMIC Settings vs. HIC¶

8.1 Ponseti Method Outcomes¶

The Ponseti method achieves excellent outcomes across settings, though some differences exist:

Outcome Measure	HIC Settings	LMIC Settings
Initial correction rate	95–98%	85–95%
Relapse rate (at 2–4 years)	10–20%	20–40%
Brace compliance	70–90%	30–60%
Need for extensive surgery	5–10%	15–30%
Functional outcomes (walking ability)	Excellent	Good to excellent (in treated patients)

(unverified)

8.2 Factors Affecting Outcomes in LMICs¶

Late presentation: Many children present after the optimal treatment window (birth–3 months)
Brace non-compliance: The most significant factor in higher relapse rates; driven by cost, access, cultural factors, and lack of follow-up infrastructure
Follow-up attrition: Loss to follow-up rates of 20–50% reported in some LMIC programs
Provider experience: Outcomes improve with increasing provider experience and established programs
Severity distribution: Some LMIC studies report higher proportions of severe/complex clubfoot

8.3 Key Studies¶

Pirani et al. (2009, 2015): Demonstrated excellent Ponseti outcomes in Uganda and other African settings when compliance was maintained (unverified)
Shrestha et al. (2019): Reported outcomes from Nepal showing good correction rates with community-based follow-up (unverified)
McElroy et al. (2017): Compared outcomes between physician and non-physician providers in LMICs; no significant difference for initial correction (unverified)

Evidence: Level 2b (cohort studies). Multiple prospective and retrospective cohort studies from LMIC settings; see above citations.

8.4 Quality Improvement Efforts¶

Recent efforts have focused on improving LMIC outcomes through:

Standardized outcome reporting: Development of international clubfoot outcome databases
Brace design innovation: Steenbeek, locally fabricated, and low-cost commercial braces
Mobile health (mHealth): SMS reminders and telemedicine for follow-up
Community-based rehabilitation (CBR): Integrating clubfoot follow-up into existing community health structures

9. Barriers to Treatment¶

9.1 Distance and Geography¶

Many families in rural LMICs must travel 50–200+ km to reach the nearest clubfoot clinic
The Ponseti method requires 5–7 weekly visits for casting, plus regular follow-up for bracing
Transportation costs can equal or exceed treatment costs
Some programs have addressed this through satellite clinics and mobile outreach

9.2 Financial Barriers¶

Direct costs: Casting materials, braces, surgical fees
Indirect costs: Transportation, lost wages, accommodation
In many settings, clubfoot treatment is not covered by public health insurance
A single course of Ponseti treatment costs approximately $200–500 USD in LMICs (including all visits and braces), which is catastrophic for families earning <$ 2/day (unverified)
Late surgical correction costs $1,000–5,000+ USD and has worse outcomes (unverified)

9.3 Provider Shortage¶

Sub-Saharan Africa: Approximately 0.1 orthopedic surgeons per 100,000 population (vs. 5–7 per 100,000 in HICs) (unverified)
Many African countries have fewer than 10 orthopedic surgeons serving populations of millions (verified against PubMed)
Ponseti training of non-physician providers has partially addressed this gap but remains insufficient
Physiotherapy workforce similarly limited in many LMICs

9.4 Cultural and Informational Barriers¶

Low awareness: Many parents and community members are unaware that clubfoot is treatable
Stigma: Families may delay treatment due to shame or social pressure
Traditional healers: First point of contact for many families; may delay evidence-based treatment
Decision-making dynamics: Healthcare decisions may involve extended family members, delaying treatment initiation

9.5 Health System Barriers¶

Fragmented referral pathways: Prenatal diagnosis (when available) may not connect to treatment services
Lack of national clubfoot protocols: Many countries lack standardized treatment guidelines
Inadequate data systems: Inability to track patients across the care continuum
Competition for resources: Clubfoot competes with infectious diseases, malnutrition, and other pressing health priorities

Evidence: Level 4 (mixed qualitative and quantitative). Drew et al. (2018); Owen et al. (2018); Harmer & Rhatigan (2014).

10. Evidence Summary Table¶

Claim	Evidence Level	Key Source(s)	Verification Status
Global incidence 1–4/1,000 live births	Level 1 (systematic review)	Smythe et al. (2017)	✅ VERIFIED
80% of cases in LMICs	Level 1	Smythe et al. (2017)	✅ VERIFIED
Only 15% of LMIC cases receive treatment	Level 4 (qualitative synthesis)	Drew et al. (2018)	⚠️ UNVERIFIED (specific %)
Ponseti method achieves >95% initial correction in HICs	Level 1 (systematic review)	Multiple SRs/metas	⚠️ UNVERIFIED (specific %)
Ponseti method achieves 85–95% correction in LMICs	Level 2b (cohort studies)	Pirani, McElroy, Shrestha	⚠️ UNVERIFIED (specific %)
Task-shifting is safe and effective for Ponseti	Level 2b (cohort with comparison)	McElroy et al.	⚠️ UNVERIFIED (specific paper)
Brace non-compliance is primary cause of relapse in LMICs	Level 2b	Multiple cohort studies	✅ Generally accepted
Cultural beliefs influence treatment-seeking	Level 4 (qualitative)	Drew et al. (2018)	✅ VERIFIED
Late surgical correction has inferior outcomes to Ponseti	Level 1 (systematic review)	Multiple SRs	✅ Generally accepted
Ponseti treatment is cost-effective in LMICs	Level 4 (economic modeling)	Program evaluations	✅ Generally accepted
Māori/Polynesian populations have highest prevalence	Level 3 (cross-sectional)	Ethnic epidemiology studies	✅ VERIFIED (Wikipedia/Clubfoot)
Han Chinese populations have lowest prevalence	Level 3	Ethnic epidemiology studies	✅ VERIFIED (Wikipedia/Clubfoot)
STEPS Steenbeek brace effective in LMIC settings	Level 4 (case series)	STEPS program data	⚠️ UNVERIFIED (attribution)
CURE International has treated >100,000 patients	Level 5 (program report)	CURE organizational data	⚠️ UNVERIFIED (specific number)
Distance to clinic is major barrier in rural LMICs	Level 4	Multiple qualitative/program studies	✅ Generally accepted

11. Oxford CEBM Evidence Grading Key¶

Level	Description
1	Systematic reviews of RCTs; meta-analyses
2a	Systematic reviews of cohort studies
2b	Individual cohort studies; low-quality RCTs
3a	Systematic reviews of case-control studies
3b	Individual case-control studies
4	Case series; poor-quality cohort/case-control studies; qualitative research
5	Expert opinion without explicit critical appraisal; mechanistic reasoning; program reports

12. Future Directions¶

12.1 Key Priorities¶

Integration into national health systems: Move from NGO-dependent programs to government-supported, sustainable services
Prenatal screening and referral: Expand prenatal ultrasound in LMICs with pathways to early treatment
Brace innovation: Develop ultra-low-cost, culturally appropriate, locally manufacturable braces
mHealth and telemedicine: Leverage mobile technology for follow-up, compliance monitoring, and remote mentoring
Workforce development: Continue task-shifting with robust training and quality assurance systems
Data systems: Establish national and international clubfoot registries for outcome tracking
Research agenda: More RCTs from LMIC settings; long-term outcomes studies; cost-effectiveness analyses

12.2 Global Targets¶

The global clubfoot community has increasingly called for:

Universal access to Ponseti treatment by 2030
Integration of clubfoot into WHO's disability and rehabilitation agenda
Recognition of untreated clubfoot as a public health priority in LMICs
Sustainable financing mechanisms for clubfoot treatment programs

References¶

Smythe T, Kuper H, Macleod D, Foster A, Lavy C. Birth prevalence of congenital talipes equinovarus in low- and middle-income countries: a systematic review and meta-analysis. Trop Med Int Health. 2017;22(3):269-285. PMID: 28000394. (verified against PubMed)
Drew S, Gooberman-Hill R, Lavy C. What factors impact on the implementation of clubfoot treatment services in low and middle-income countries? BMC Musculoskelet Disord. 2018;19(1):72. PMID: 29499667. (verified against PubMed)
Owen RM, Capper B, Lavy C. Clubfoot treatment in 2015: a global perspective. BMJ Global Health. 2018;3(4):e000852. PMID: 30233830. (verified against PubMed)
Harmer L, Rhatigan J. Clubfoot care in low-income and middle-income countries: from clinical innovation to a public health program. World J Surg. 2014;38(4):839-848. PMID: 24213946. (unverified)
Dobbs MB, Gurnett CA. Update on clubfoot: etiology and treatment. Clin Orthop Relat Res. 2009;467(5):1146-1153. PMID: 19224303. (verified against PubMed)
Gibbons PJ, Gray K. Update on clubfoot. J Paediatr Child Health. 2013;49(9):E434-E437. PMID: 23586398. (verified against PubMed)
O'Shea RM, Sabatini CS. What is new in idiopathic clubfoot? Curr Rev Musculoskelet Med. 2016;9(4):470-477. PMID: 27696325. (unverified)
Dibello D, et al. What a paediatrician should know about congenital clubfoot. Ital J Pediatr. 2020;46(1):78. PMID: 32498693. (unverified)
Ganesan B, et al. Ponseti method in the management of clubfoot under 2 years of age: A systematic review. PLoS One. 2017;12(6):e0178299. PMID: 28632733. (verified against PubMed)
Chen C, et al. Clubfoot Etiology: A Meta-Analysis and Systematic Review. J Pediatr Orthop. 2018;38(8):e462-e469. PMID: 29917009. (unverified)
Morcuende JA, et al. Results of an accelerated Ponseti protocol for clubfoot. J Pediatr Orthop. 2005;25(5):623-626. PMID: 16199943. (unverified)

Last updated: May 2026Evidence grading: Oxford Centre for Evidence-Based Medicine (CEBM) 2011 Levels of EvidenceAudit: May 2026 — see verification header at top of document for details